Though ClpP agonists were found to inhibit cell proliferation in breast cancer and other cancer cell models, the anti-cancer mechanism of action is just beginning to be elucidated [33,35,39,42,70,71,72,73,74]. This evidence concerns the gene CLPP and breast carcinoma.